No Detail Found!

Comparative bioequivalence and pharmacokinetics of ciprofloxacin in healthy male subjects.

Author(s)
Muhammad Khalid Khan Faculty of Pharmacy, Gomal University, Dera Ismail Khan, Pakistan
Muhammad Farid Khan Faculty of Pharmacy, Gomal University, Dera Ismail Khan, Pakistan
Abstract
Pharmacokinetics and bioequivalence studies of two ciprofloxacin tablet brands (trial batch of Ciprofloxacin (Test) & Reference) were conducted in 14 healthy male volunteers after oral administration. Each brand (test and reference) consisted of 500 mg of ciprofloxacin. The drug was analyzed in plasma samples with a microbiological assay using Streptococcus faecalis as test organism. The elimination half-life of 3.00 ± 0.21 and 3.28±0.11 h was calculated for both brands. The peak plasma concentrations of (3.59±0.26 ug/mL) and (3.34±1.20 ug/mL) was attained in about 1.48±0.11 hour and 1.47±0.05 for both Test and Reference ciprofloxacin respectively. The mean ± SE values for total area under the curve (AUC O-∞) were 26.15 ±1.35, and 24.95±0.93 hmg/1 for both test and reference tablets respectively. The mean ± SE values of clearance were 24.83±1.63 and 24.73±1.11 1/h for both formulations respectively. The ratio of elimination rate constant Kel [l/h] was 1.14 percent difference between the test and reference tablets and likewise, half-life (t1/2β) expressed in hours showed the ratio of 0.91 percent. This study indicated that all the pharmacokinetic and bioequivalence parameters for both ciprofloxacin formulations are statistically non-significant, hence both formulations are bioequivalent.
Publication Details
Page(s) 1-7
DOI DOI not available
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 22, Issue: 1, Year: 2009

Request the full text from PASTIC

0

Citations

0

Downloads

90

Views